Skip to main content

Incidence of Obesity/Overweight in PsA: Four in Five

Dr. Antoni Chan | Abstract 2015 | ACR 2026 Orlando

Transcription

I'm Anthony Chan reporting here for RheumNow in Orlando at ACR 2026, and there are lots of abstracts presented here at ACR 2026 regards to obesity and also the use of new agents such as the incretins GLP-1 presented here, particularly in the field of psoriatic arthritis. But today I want to highlight to you an important abstract 2015, and this is to look at what is the actual incidence or prevalence of obesity, or patients being overweight, in the psoriatic arthritis group.

This came from a big US study where they looked at nearly 20 million US health records. And they looked at the patients who had psoriasis and also psoriatic arthritis in this cohort. And what they found quite strikingly is that four in five patients with psoriatic arthritis were either classified as overweight or obese, compared to 73.4% in the non-PsA group. And what was also striking is that if the patients had obesity, then the hazard ratio of developing psoriatic arthritis, if they already had psoriasis, was much higher at 1.8.

The key takeaways from this is that four in five of our patients from this cohort were either overweight or obese. That means that this is the challenge that is facing us in terms of what we see in our clinic. The important thing is that this is modifiable. So we can look into ways where we can actually have a discussion and also a treatment plan for obesity in patients who are overweight in psoriatic arthritis. A little caveat — this is an observational cohort, so we cannot look at causation directly, but this is an important association that we could possibly look at.

My key takeaways are three. Firstly, four in five of our patients with psoriatic arthritis in this cohort are either overweight or obese. So we should have the ability to ask and discuss the management of weight control in this group of patients in order to get better outcomes. Secondly, there is a two times risk of a patient who has psoriasis developing psoriatic arthritis if they're overweight or obese — so another area where we could potentially tackle this issue. And finally, weight management should be part of our overall management for patients with psoriatic arthritis. It shouldn't just be a number that we record, but it should very much be a target for what we treat.

So I'm Anthony Chan reporting here for RheumNow, ACR 2026.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×